Cargando…
Phase II Study to Topotecan and Cisplatin in Advanced Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma remains a highly chemoresistant neoplasm and is a common malignancy with poor prognosis in Korea. We performed a phase II study to evaluate the efficacy and toxicities of topotecan and cisplatin combination chemotherapy for advanced hepatocellular carcinoma. METH...
Autores principales: | Lee, Ga Young, Kim, Bong-Seog, Seo, Yeoung Tae, Choi, Seong Ho, Kim, Hye Jin, Choi, Dong Seog, Ko, Ji Young, Yang, Soo Hyun, Byun, Jong Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531618/ https://www.ncbi.nlm.nih.gov/pubmed/12872448 http://dx.doi.org/10.3904/kjim.2003.18.2.104 |
Ejemplares similares
-
A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
por: Kang, Jin-Hyoung, et al.
Publicado: (2020) -
The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
por: Moon, Ji Young, et al.
Publicado: (2018) -
Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer
por: Kim, Miso, et al.
Publicado: (2017) -
Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy
por: Lee, Myung-Won, et al.
Publicado: (2020) -
The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma
por: Kang, Keunhee, et al.
Publicado: (2015)